enGene Holdings Inc ENGN
News
enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update
enGene to Participate in Upcoming Investor Conferences
enGene Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
enGene Announces Appointment of Ron Cooper as Chief Executive Officer
NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors